Introduction
It has been clearly shown that prostaglandin E,, E2 and I2 (PGE,, PGE2, PGI2) produce hyperalgesia (Ferreira, 1972; Ferreira et al., 1973; Ferreira et al., 1978b; James & Church, 1978) . This phenomenon has been used to explain both the hyperalgesia which occurs in inflamed tissues in which prostaglandin levels are elevated, and the analgesic effects of prostaglandin biosynthesis inhibitors in such situations (Vane, 1971; Moncada et al., 1978; Ferreira, 1981) . However, it is not yet clear which of the prostaglandins found in inflamed tissues plays the most important role in the hyperalgesia of inflammation. Also, the quantitative relationships between prostaglandin levels and the pain response have not been delineated. A recently described model, the nociceptive response and inflammation induced by intraperitoneal injection of zymosan in mice (Doherty et al., 1984; Doherty et al., 1985a,b) , offers the opportunity to resolve some of 'Author for correspondence. these questions. In this model, it has proved possible to measure the levels of several relevant arachidonic acid metabolites, in addition to quantifying the inflammatory and nociceptive (writhing) responses. The present report describes studies with this model which identify PGI2 as the prostaglandin of greatest importance in the writhing response to zymosan and clarify the mechanism of action of some analgesic agents. A preliminary report of this work was presented at the 2nd World Congress on Inflammation, Antirheumatics, Analgesics, Immunomodulators (Monaco, March 19-22, 1986 ).
Methods
The methods for the study of zymosan-induced writhing and inflammation have been described previously (Doherty et al., 1985a) . Briefly, this involves intraperitoneal injection of I mg of zymosan (Sigma i) The Macmillan Press Ltd 1987 Chemical Co, St. Louis, MO, U.S.A.), suspended in 0.9% w/v sodium chloride (0.5ml, unless otherwise indicated) into male mice (CD1, Charles River Breeding Labs, Wilmington, MA, U.S.A., 20-35 g body weight) which had been pretreated with test compounds or vehicle. Writhes were counted by an observer unaware of the allocation of treatments. At an appropriate time after injection of zymosan, the mice were killed by cervical dislocation and the peritoneal cavity lavaged with 2 ml of saline. Proteins were removed from the lavage fluid by addition of ethanol to 80% v/v followed by centrifugation. The supernatants were dried at 40'C under a constant stream of nitrogen and stored at -70'C until assayed.
For assays by gas chromatography/mass spectrometry (g.c./m.s.), prostaglandins were first extracted (Powell, 1980) and then derivatized (Waddell et al., 1983) as follows: To each tube ofdried peritoneal fluid was added deuterated PGF2,, as internal standard, and 1 ml of water adjusted to pH 3 with IN HCl. After vigorous vortexing, the sample was passed over a preconditioned column of octadecylsilyl silica (C18 minicolumn, J.T. Baker, Phillipsburg, NJ, U.S.A.), which was washed with 2ml aliquots of water, ethanol/water (15:85) and petroleum ether, then eluted with 2ml of ethyl formate. The ethyl formate was removed by evaporation under nitrogen and carbonyl groups derivitized with I00 pl of 5 mgml-' methoxyamine hydrochloride in pyridine (38°C for 1 h). After drying under nitrogen, the carboxylic acid groups were derivitized with 30 fil of acetonitrile, 10 pl of penta- (Steel & Torrie, 1960) , or, when homogeneity of variance problems made analysis of variance inappropriate by multiple t-tests, with Bonferoni's adjustment (Neter & Wasserman, 1974) . For comparison of proportions (e.g. % of mice writhing), Fisher's exact test was used and for assessment ofthe significance ofthe linear relationship between parameters, least squares regression was performed (Steel & Torrie, 1960) .
Results
It was previously reported (Doherty et al., 1985a ) that 1 mg of zymosan (in an injection volume of 0.5 ml) produced the optimum writhing response; higher doses administered in the same volume did not increase the number of writhes. As shown in Figure 1 , when 1 mg was administered in 5 ml of saline, the response was much reduced and occurred with a longer latency after injection. When I mg was administered in 0.05 ml of saline, the response was similar in time course to that of I mg per 0.5 ml, but much reduced in magnitude (Figure 1 ). Therefore, in all subsequent studies, I mg per 0.5 ml has been used and writhes counted for a 15 min period, either 5-20, 10-25 or 15-30 min after injection of zymosan. The 15 min period selected for a particular experiment was that which coincided with the period of highest number of writhes in a preliminary test. In a number of studies, the levels of immunoreactive PGE2 were measured and the writhes were counted in mice pretreated with various anti-inflammatory and analgesic agents at doses previously shown to inhibit writhing completely. The prostaglandin biosynthesis inhibitors (indomethacin, aspirin, ibuprofen) reduced both PGE2 levels and the number of writhes (Table 1) . Morphine inhibited writhing but had no statistically significant effect on PGE2 levels (Table 1) . Pooling data from all experiments (including all vehicle and drug-treated groups, except those treated with morphine) suggests that there is a relationship between the level ofPGE2 and the writhing response (Figure 2a,b) . However, although there is a significant linear relationship between the number of writhes per mouse and the level of PGE2 (P = 0.0128), the correlation (r = 0.1838) is weak ( Figure 2a) . The relationship between these two parameters is more obvious when the proportion of mice writhing, regardless of the number of writhes, is considered ( Figure 2b) . The higher the level of PGE2, the higher the percentage of mice that writhe. However, it should be noted that in the experiments shown in Figure 2 , mice were killed at different times after injection of zymosan in order to enable additional parameters to be measured (protein accumulation which peaks I h after zymosan injection; peptidoleukotriene levels which peak 15 -30 min after injection, data not shown). This experimental variable could have obscured a stronger correlation between PGE2 and the number of writhes.
The data from morphine-treated mice have been excluded from the analysis discussed above since they clearly exhibit a different pattern of response. All ten mice treated with 10mg kg-' s.c. morphine had PGE2 levels> 0.055 ng per mouse, but none of them writhed. This was significantly different from the 131 mice in Figure 2 which also had PGE2 levels > 0.055 ng per mouse, of which 15 writhed (Fisher's exact test, P<0.01).
The ability of exogenous PGE2 to reverse the inhibition of writhing induced by indomethacin was examined. In animals pretreated with indomethacin (1 mg kg-', orally) and injected with zymosan, no writhing occurred, as shown in Table 1 and previously (Doherty et al., 1985a) . Intraperitoneal injection of PGE2 at a wide range of doses (2 ng to 2 jig per mouse) and times (3 h before to 10 min after zymosan) failed to The failure ofthe above experiments to demonstrate reversal of the analgesic activity of indomethacin by administration of exogenous PGE2 suggested that another cyclo-oxygenase product (or products), whose synthesis would also be inhibited by indomethacin, could be involved in mediating the writhing response. Therefore, g.c./m.s. was used to look at the levels of other cyclo-oxygenase products. PGE2 and PGD2 are positional isomers which produce derivatives with identical mass, and their oximine derivatives exist as syn and ante isomers. The g.c. resolves these four compounds with identical mass (524 atomic mass units) into three peaks, one ofwhich is a mixture ofone PGE2 oxime isomer and one PGD2 oxime isomer (peak 1 ofFigure 3). The other two peaks contain only PGD2 or only PGE2 derivatives (peaks 2 and 3 respectively in Figure 3 ). Peritoneal fluid collected 15 min after zymosan injection clearly contained more PGE2 than peritoneal fluid from non-injected mice (Figure 3) . However, the levels ofPGE2 were very low (< 4 ng per mouse) and close to the limits ofdetection ofthe assay, so they have not been quantified. These data are consistent with those obtained with the RIA assay ( Table 1) . PGD2 levels are also found to be extremely low (<4 ng per mouse) and no difference between non-injected and zymosan-injected mice was seen. No TxB2 was detected in either non-injected or zymosaninjected mice (i.e. < Ing per mouse). In marked contrast, 6-keto-PGF,., the non-enzymatic breakdown product of PGI2, was found in readily measurable amounts in both non-injected and zymosan-injected mice (Figure 3 ). Fifteen minutes after zymosan injection, the levels were 20 times higher (228 ng per mouse) than in controls (9 ng per mouse) but fell rapidly thereafter (Figure 4) , indicating the transient synthesis of a relatively large amount of PGI2.
Since the g.c./m.s. data indicated that PGI2 was the major cyclo-oxygenase product formed, an RIA assay for 6-keto-PGF1. was used to examine the relationship between PGI2 and the writhing response. The levels of 6-keto-PGF,, detected by RIA were consistent with those detected by g.c./m.s. (Table 2 ). In order to measure the writhing response and also 6-keto-PGF,, levels at a time close to their transient peak level, writhes were counted from 5 to 20 min after zymosan injection, the mice immediately killed, and peritoneal washing collected. The prostaglandin biosynthesis inhibitors examined (indomethacin, ibuprofen) reduced the levels of 6-keto-PGFj at doses effective in reducing the number ofwrithes (Table 2 ). In fact, these compounds reduced the 6-keto-PGF,1 to levels below those found in mice which had received no zymosan. In contrast, morphine and clonidine inhibited writhing without reducing the levels of 6-keto-PGF,1 (Table   2 ).
An analysis of the correlation between levels of 6-keto-PGFia, and the writhing response is shown in Figure 5a ,b. In this analysis, clonidine and morphine data are excluded. There is a significant linear relationship between the level of6-keto-PGFg and the number of writhes (P = 0.0001) but with a poor correlation (r = 0.4276) (Figure 5a ). The proportion of mice which writhed, regardless of the number of writhes, In view of the correlation described above, the ability of PGI2 to reverse the inhibition of writhing observed with indomethacin was examined. When injected intraperitoneally, 10min after the i.p. injection of zymosan, PGI2 reversed the analgesic effect of indomethacin ( Figure 6 ). The effective doses of PGI2 were in the range of those found in the peritoneal cavity of untreated zymosan-injected mice. Clonidine, morphine and pentazocine, but not ibuprofen, were able to block the reversal of the analgesic activity of indomethacin induced by i.p. administration of PGI2 (2000 ng per mouse) (Table 3) .
PGI2 induced writhing when injected into otherwise untreated mice, although the incidence was low (6 of the 20 mice injected with 2000 ng of PGI2 in 0.5 ml pH 10 carbonate buffer, writhed; none of the 20 mice injected with buffer alone writhed; P <0.05, Fisher's exact test). In both of the above situations, the writhing induced by PGI2 had a short latency to onset (< I min) and was of short duration (< 10 min).
Discussion
The data described here confirm the usefulness of this model in the study of mediators of nociceptive responses and inflammation. However, it is clear that apparently trivial methodological details can be critically important. There is no obvious reason why All compounds were administered I h before intraperitoneal administration of zymosan (I mg in 0.5 ml). Writhes were counted 5 to 20 min after zymosan injection and the animals were then killed to collect peritoneal fluid samples. Doherty et al., 1985a) indicating the presence of increased amounts of PGE2 following zymosan injection, although the levels were relatively low (<2 ng per mouse). PGD2 and TxB2 were not increased, but 6-keto-PGFi. was increased 20 fold and reached levels (228 ng per mouse) which were much higher than those of the other prostanoids examined. Somewhat similar data have been reported by Pacholok et al. (1986) . Therefore, it is clear that zymosan induced the rapid, but transient, synthesis of relatively large amounts of PGO2 and a small amount of PGE2. This synthetic activity is over and prostaglandin levels are falling towards normal before inflammatory cells arrive in the peritoneal cavity (Doherty et al., 1985a) . Resident peritoneal cells are therefore responsible for the synthesis of PGO2 and PGE2. Although mouse peritoneal macrophages synthesize both of these prostaglandins when stimulated with zymosan in vitro, they synthesize 3 to 4 times more PGE2 than PGO2 (Humes et al., 1977; Bonney et al., 1978) . Rabbit peritoneum synthesized PGO2 when stimulated in vitro with serum in which the complement system had been activated by incubation with zymosan (Rampart et al., 1981) . Peritoneum may, therefore, contribute a major portion of the PGI2 observed in the present study. This latter study also emphasizes the role of the complement system in the response to zymosan, as has been also described in the rabbit (Jose et al., 1983) .
The effects of analgesic agents on prostaglandin levels enabled them to be classified into two groups: (A) the non-steroidal anti-inflammatory drugs (indomethacin, ibuprofen, aspirin) reduced the levels of both PGE2 and 6-keto-PGFg at analgesic doses. This is consistent with the ability of these drugs to inhibit cyclo-oxygenase (Vane, 1971; Shen, 1978) , the enzyme responsible for the synthesis of PGH2, the immediate precursor of these prostaglandins (Flower, 1978) . These data, however, do not indicate whether PGE2, PGI2, or both, are involved in the writhing response. (B) In contrast, morphine and clonidine did not significantly reduce the levels of prostaglandins at analgesic doses. This is consistent with the consensus of opinion that these drugs exert their analgesic effect via stimulation of opiate (Pert & Snyder, 1973) or a2-adrenoceptors (Paalzow & Paalzow, 1976) respectively, and not by inhibition of prostaglandin synthesis.
The writhing response correlated equally well with the levels of PGE2 and the levels of 6-keto-PGF,1. This is not surprising since the synthesis of both is dependent on the activity ofcyclo-oxygenase (Flower, 1978) . In order to determine whether these relationships were causal, the ability of i.p. administration of PGE2 and PGI2 to reverse the analgesic effects of an agent which reduces the levels of both, indomethacin, was examined. PGE2 proved to be completely ineffective over a wide range of doses, including those found following zymosan injection, in reversing indomethacin analgesia, suggesting that it is not involved in mediating the writhing response to zymosan. This result was surprising, since other reports have described the ability of intraperitoneal doses of PGE2 to induce writhing (Collier & Schneider, 1972; Dubinsky & Schupsky, 1984) and to reverse the ability of indomethacin to inhibit benzoquinone-induced writhing in mice (James & Church, 1978) . No explanation for this discrepancy can be offered at present. In marked contrast to the lack of effect of PGE2, PGI2 completely reversed the analgesic effect of indomethacin at doses similar to those found in the peritoneal cavity of control zymosan-injected mice. Furthermore, PGI2 induced writhing when injected into otherwise untreated mice. Similarly, Smith et al. (1985) found that i. (Ferreira et al., 1978a; Okuyama & Aihara, 1985) , their mechanism is entirely peripheral in zymosaninduced writhing.
In summary, the data described here directly confirm previous suggestions that PGI2 is an important mediator of inflammatory pain and that cyclooxygenase inhibitors exert their analgesic activity by inhibiting PGI2 synthesis at the site of the inflammation. It remains to be seen whether the same is true of other animal models of inflammatory pain and in inflammatory pain in man.
